(c) 2024 PillSync.com

nirogacestat 50 mg

1 INDICATIONS AND USAGE OGSIVEO is indicated for adult patients with progressing desmoid tumors who require systemic treatment. OGSIVEO is a gamma secretase inhibitor indicated for adult patients with progressing desmoid tumors who require systemic treatment. ( 1 )

SpringWorks Therapeutics, Inc.


7 months ago ROUND ORANGE 50 nirogacestat 50 mg

ROUND ORANGE 50

7 months ago ROUND ORANGE 50 nirogacestat 50 mg

50 ROUND ORANGE

16 HOW SUPPLIED/STORAGE AND HANDLING OGSIVEO (

NIROGACESTAT) is supplied as 50 mg, 100 mg, and 150 mg tablets. Each 50 mg orange, film-coated tablet is debossed with a “50” on one side. Each 100 mg light orange, film-coated tablet is debossed with a “100” on one face. Each 150 mg orange yellow, film-coated tablet is debossed with a “150” on one face. The 50 mg tablets are packaged in high density polyethylene (HDPE) bottles with child-resistant closures. Each bottle contains 180 tablets: NDC # 82448-050-18. The 100 and 150 mg tablets are packaged in 14 count blister cards with child resistant closure (100 mg - NDC #82448-100-14; 150 mg - NDC #82448-150-14). Store at 20°C-25°C (68°F-77°F). Excursions permitted between 15°C-30°C (59°F-86°F). See USP Controlled Room Temperature.


More pills like ROUND 50

Related Pills

nirogacestat 100 mg

springworks therapeutics, inc.

eplerenone 50 mg

westminster pharmaceuticals, llc

quetiapine 50 mg

Sun Pharmaceutical Industries, Inc.

quetiapine 50 mg

accord healthcare inc.

quetiapine 50 MG Oral Tablet

Sun Pharmaceutical Industries, Inc.

Acetaminophen 650 mg Hydrocodone 10 mg

watson laboratories, inc.

Prednisone 20 MG Oral Tablet

Qualitest Pharmaceuticals

topiramate 50 MG Oral Tablet

Glenmark Generics Inc., USA












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site